Mice with an OPMD-like disease treated with cystamine showed improved strength and muscle function and fewer cellular abnormalities
posted on June 9, 2010 - 12:43pm
Scientists in the United Kingdom have found that mice carrying a genetic mutation that causes oculpharyngeal muscular dystrophy (OPMD) in humans and showing a disease resembling human OPMD benefited from treatment with a chemical called cystamine, provided in their drinking water.
About the new findings
David Rubinsztein and colleagues at the University of Cambridge announced their findings June...